Military Medicine

署名仅限于对所描述工作的设计和执行做出重大贡献的人员。参与未达到署名标准的贡献者应被致谢但不列为作者。期刊将在投稿时联系所有列名作者以确认其角色。期刊不允许幽灵署名（未具名作者撰写文章却无署名）或 guest/gift 署名（贡献甚微或无贡献者被列为作者）。 模型中文摘要

Authorship is limited to those who have made a significant contribution to the design and execution of the work described. Any contributors whose participation does not meet the criteria for authorship should be acknowledged but not listed as an author. The Journal will contact all listed authors at the point of submission to confirm their role. The Journal does not allow ghost authorship, where a…

当作者（或其机构或雇主）拥有可能影响（或使偏见）作者决策、工作或稿件的经济或个人关系或隶属关系时，可能存在利益冲突。所有作者必须披露其作为作者可能拥有的任何潜在利益冲突，例如对稿件所涵盖主题拥有经济利益。并非所有利益冲突都必然使论文无效或取消作者资格。向编辑充分披露具体情况将使期刊能够做出知情且合理的决定。 模型中文摘要

A conflict of interest may exist when an author (or the author’s institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author’s decisions, work, or manuscript. All authors must disclose any potential conflict of interest they may have as authors, such as having a financial interest in the topic covered by the manuscript. Not all conflic…

期刊鼓励所有作者在伦理允许的情况下公开释放已发表论文所基于的所有数据。作者必须在已发表的文章中包含数据可用性声明。 模型中文摘要

The journal encourages all authors, where ethically possible, to publicly release all data underlying any published paper. Authors must include a Data Availability Statement in their published article. Please see the Oxford Academic policy and sample statements.

作者应遵守由出版伦理委员会（COPE）和国际医学期刊编辑委员会（ICMJE）制定的出版伦理高标准。伪造或捏造数据；剽窃，包括未经适当引用而重复发表作者自己的作品；以及盗用他人工作，都是不可接受的做法。伦理不端行为案件将被非常严肃地对待，并将根据 COPE 指南进行处理。 模型中文摘要

Authors should observe high standards with respect to publication ethics as set out by the Commission on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE). Falsification or fabrication of data; plagiarism, including duplicate publication of the authors’ own work without proper citation; and misappropriation of work are all unacceptable practices. Cases of eth…

为了在文章中复制任何第三方材料（包括表格、图表或图像），作者必须获得版权持有者的许可，并遵守版权持有者对此类重用可能提出的任何要求。在寻求复制任何类型的第三方材料时，作者应请求：在指定文章和期刊中复制材料的非排他性权利；印刷和电子权利，最好用于任何形式或媒介；在作品存续期间使用材料的权利；以及全球英语语言权利。 模型中文摘要

In order to reproduce any third party material, including tables, figures, or images, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse. When seeking to reproduce any kind of third party material authors should request the following: non-exclusive rights to reproduce the material in t…

Military Medicine offers the option of publishing under either a standard licence or an open access licence. Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please do clarify any such requirements with your funder or institution. Should you wish to publish your article open access, you shoul…

The Editor-in-Chief will first determine if a submitted manuscript is suitable for further review. Manuscripts are sent for peer-review by reviewers who are selected based on their expertise related to the content of the manuscript. After the reviews are received by the Managing Editor of the Journal, the paper is sent to one of the Editors of Military Medicine who will act as the Handling Editor.…

编辑部仔细监控提交给 Military Medicine 的论文是否存在剽窃。我们将剽窃定义为：逐字复制——未经许可和未确认原始来源而逐字复制作品（全部或部分）；改写——未经许可和未确认原始来源而复制他人想法（非逐字复制）；大量复制——从其他来源复制图像或数据；文本回收——重复使用您自己以前出版物中的大量文本。 模型中文摘要

The editorial office carefully monitors papers submitted to Military Medicine for plagiarism. We define plagiarism to include: literal copying - reproducing a work word for word, in whole or in part, without permission and acknowledgment of the original source; paraphrasing - reproducing someone else's ideas while not copying word for word, without permission and acknowledgment of the original sou…

作者保留通过各种渠道提供作者原始版本（预印本）的权利，这不妨碍向期刊投稿。如果被接受，作者需要更新任何预印本的状态，包括您已发表论文的 DOI，如我们的作者自存档政策页面所述。 模型中文摘要

Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiv…

有关此期刊政策的信息，请访问我们的作者自存档政策页面。 模型中文摘要

For information about this journal's policy, please visit our Author Self-Archiving Policy page.

Clinical trial registration required. 模型摘要

In accordance with the Food and Drug Administration Modernization Act of 1997, the FDA Amendment Act of 2007, and the policies of the ICMJE, authors are required to register all clinical trials assigning patients to intervention or treatments groups in ClinicalTrials or other ICMJE recognized clinical trial databases. Clinical trials must be registered prior to the enrollment of the first patient.…